Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human HLA-C Protein, N-His

Catalog #:   YHC80601 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P10321
Protein length: Ser48-Thr305
Overview

Catalog No.

YHC80601

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser48-Thr305

Predicted molecular weight

31.82 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P10321

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

HLA-Cw, HLA-C, Human leukocyte antigen C, HLAC, HLA class I histocompatibility antigen, C alpha chain

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human HLA-C protein
References

Characterization of HLA-A/HLA-B/HLA-C/HLA-DRB1 Haplotypes in Romanian Stem Cell Donors Through High-Resolution Next-Generation Sequencing., PMID:40508057

Comprehensive Mendelian randomization analysis and experimental investigation identifies the causal relationship between immunity and kidney stone disease., PMID:40498118

Predominant T-cell epitopes of SARS-CoV-2 restricted by multiple prevalent HLA-B and HLA-C allotypes in Northeast Asia., PMID:40469303

Characterisation of the Novel HLA-A*68:326 and -C*02:254N Alleles by Two Different Sequencing-Based Typing Techniques., PMID:40462530

ESMpHLA: Evolutionary Scale Model-Based Deep Learning Prediction of HLA Class I Binding Peptides., PMID:40405507

Investigating the role of necroptosis in the immunological microenvironment of periodontitis., PMID:40402323

Characterisation of the Novel HLA-C*08:272 Allele by Next-Generation Sequencing in a Chinese Donor., PMID:40396713

Shared neoantigens' atlas for off-the-shelf cancer vaccine development., PMID:40390041

Detection of Five New and Confirmation of Three HLA-C Alleles., PMID:40387370

Characterisation of the Novel HLA-C*04:538 Allele by Third-Generation Sequencing., PMID:40387236

The Novel HLA-C*07:1088 Allele Characterised by Two Different Sequencing-Based Typing Techniques., PMID:40375776

HLA Polymorphisms and COVID-19 Susceptibility and Severity: Insights From an Iranian Patients Cohort., PMID:40366340

Study on γδT-Cell Degranulation at Maternal-Fetal Interface via iKIR-HLA-C Axis., PMID:40358173

Four New Variants of HLA-C Identified by Next-Generation Sequencing., PMID:40357639

Genome-wide Mendelian randomization study identifies therapeutic targets for diabetic microangiopathy., PMID:40349847

Identification of the Novel HLA-C*03:641 Allele in a Chinese Cord Blood Donor., PMID:40346883

Recognition of the HLA-C*05:37 Allele in a Taiwanese Individual., PMID:40346001

Deletion of the HLA-B Gene in One of the Inherited Haplotypes in a Northern European Family., PMID:40345160

Characterisation of the Novel HLA-C*16:01:01:42Q Allele by Sequencing-Based Typing., PMID:40342220

Proprotein convertase subtilisin/kexin type 9 contributes to cisplatin-induced acute kidney injury by interacting with cyclase-associated protein 1 to promote megalin lysosomal degradation., PMID:40339661

The Novel HLA-C Allele, HLA-C*01:285Q, With a Modified Start Codon., PMID:40326600

Characterisation of the Novel HLA-C*08:296 Allele in Two Members of a Family., PMID:40323703

First trimester extravillous trophoblast secretes HLA class I molecules via small extracellular vesicles., PMID:40300266

Down-Regulation of HLA-C Expression on Melanocytes May Contribute to the Therapeutic Efficacy of UVB Phototherapy in Psoriasis., PMID:40243413

HLA Class I and II allelic diversity among Ecuadorian transplant candidates: A comprehensive retrospective analysis., PMID:40239304

De novo donor-specific HLA antibody development after kidney transplantation is impacted by PIRCHE II score and recipient age., PMID:40236692

The Novel HLA-C Allele, HLA-C*03:595, was Identified by Sequence-Based Typing., PMID:40231690

Association of interferon regulator factor 1 upregulation with pulmonary arterial hypertension., PMID:40223959

Relevance of Human Leukocyte Antigen Class C Donor-Specific Antibodies in Kidney Transplant., PMID:40223381

Characterisation of the Novel HLA-C*07:1173 Allele by Sequencing-Based Typing., PMID:40205637

Five Novel HLA-C Alleles Identified in Unrelated Bone Marrow Volunteers., PMID:40205635

Identification of the Novel Allele, HLA-C*06:395, in a Chinese Cord Blood Donor., PMID:40195724

Characterisation of the Novel HLA-B*15:727 and HLA-C*04:01:01:194Q Alleles., PMID:40193244

Detection of Novel HLA-C*07:1165, HLA-C*07:1166, HLA-C*07:02:161 Alleles and Confirmation of HLA-C*07:02:156., PMID:40193209

Micropolymorphism outside the peptide-binding groove of human leukocyte antigen (HLA)-C*14 modulates structural stability and shapes immune responses., PMID:40185448

Recognition of the HLA-C*03:86 Allele in a Taiwanese Individual., PMID:40160143

Persistent neonatal alloimmune thrombocytopenia caused by triple anti-HLA-A11, -B3901, and -Cw7 antibodies., PMID:40159572

Identification of a Novel HLA-C*15:292 Allele by Next-Generation Sequencing., PMID:40145473

Novel HLA-A, -B, -C and -DRB1 alleles identified in the Australian New South Wales tissue typing laboratory., PMID:40132251

Characterisation of the Novel HLA-C*04:534 Allele by Sequencing-Based Typing., PMID:40117122

Discovery of the Novel HLA-C*08:301 Allele in an Individual From XinJiang, China., PMID:40117110

The Role of the Major Histocompatibility Complex Region on Chromosome 6 in Skin Atrophy: A Mendelian Randomization Study., PMID:40099350

Psoriatic arthritis phenotype may vary depending on whether the skin or joint domain appears first or whether both appear simultaneously., PMID:40095701

The influence of genetic factors on the clinical manifestations and response to systemic treatment of plaque psoriasis., PMID:40095058

Identification and biophysical characterization of Plasmodium peptide binding by common African HLAs., PMID:40074802

HLA-C*15:02:01:69Q, A New Allele With A Different Splice Site., PMID:40071351

Discovery of the Novel HLA-C*15:02:01:65Q Allele, First Identified in a Brazilian Individual., PMID:40071343

Clinical Experience of Risankizumab in Patients With a History of Erythrodermic Psoriasis., PMID:40071317

A rapid ecologic analysis, confirmed by a case-control study, identifies class I HLA alleles correlated to the risk of COVID-19., PMID:40065352

Identification of the Novel HLA-C*03:689 Allele by Sanger Dideoxy Nucleotide Sequencing., PMID:40052356

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human HLA-C Protein, N-His [YHC80601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only